BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. Management of occult hepatitis B virus infection: An update for the clinician. World J Gastroenterol 2011; 17(12): 1563-1568 [PMID: 21472122 DOI: 10.3748/wjg.v17.i12.1563]
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1563.htm
Number Citing Articles
1
Ricardo Wagner de Almeida, Francisco Campello do Amaral Mello, Isabelle Vasconcelos Menegoy, Márcia Paschoal do Espírito Santo, Cléber Ferreira Ginuíno, Paulo Sérgio Fonseca de Sousa, Livia Melo Villar, Elisabeth Lampe, Lia Laura Lewis-Ximenez. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in BrazilMemórias do Instituto Oswaldo Cruz 2017; 112(7): 485 doi: 10.1590/0074-02760160477
2
Salvatore Magrì, Luchino Chessa, Mauro Demurtas, Francesco Cabras, Giammarco Mocci. Review article: safety of new biologic agents for inflammatory bowel disease in the liverEuropean Journal of Gastroenterology & Hepatology 2021; 33(5): 623 doi: 10.1097/MEG.0000000000002076
3
Yuecheng Yu, Jinlin Hou, Masao Omata, Yue Wang, Lanjuan Li. Loss of HBsAg and antiviral treatment: from basics to clinical significanceHepatology International 2014; 8(1): 39 doi: 10.1007/s12072-013-9495-3
4
Nathalia E Cardona, Carmen L Loureiro, Domingo J Garzaro, María C Duarte, Daisy M García, Milian C Pacheco, Isabelle Chemin, Flor H Pujol. Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult casesVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-527
5
Andrea M.M. Fontenele, Natalino Salgado Filho, Adalgisa S.P. Ferreira. Occult hepatitis B in patients on hemodialysis: a reviewAnnals of Hepatology 2013; 12(4): 359 doi: 10.1016/S1665-2681(19)31335-3
6
Mingyuan Zhang, Ruihong Wu, Jing Jiang, Gerald Y. Minuk, Junqi Niu. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosisAlcohol 2013; 47(7): 553 doi: 10.1016/j.alcohol.2013.07.003
7
Rosa María Ruiz-Calero Cendrero, Bárbara Cancho Castellano, María Victoria Martín Hidalgo-Barquero, María Cruz Cid Parra, Josefa Galán González, María Antonia Fernández Solís, Olga Sánchez García. ¿Cuándo puede ser útil buscar VHB oculto en pacientes en hemodiálisis?Nefrología 2020; 40(2): 115 doi: 10.1016/j.nefro.2019.07.001
8
Ke Wang, Hao Pei, Biao Huang, Run-Lin Yang, Hang-Yuan Wu, Xue Zhu, Lan Zhu. Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis B virus infectionBrazilian Journal of Medical and Biological Research 2012; 45(12): 1112 doi: 10.1590/S0100-879X2012007500130
9
Carlo Selmi, Cecilia B. Chighizola, Angela Ceribelli, Maria De Santis, Pier Luigi Meroni, Renqian Zhong. Liver Immunology2014; : 27 doi: 10.1007/978-3-319-02096-9_3
10
Chrysoula L. Pipili, George V. Papatheodoridis, Evangelos C. Cholongitas. Treatment of hepatitis B in patients with chronic kidney diseaseKidney International 2013; 84(5): 880 doi: 10.1038/ki.2013.249
11
Stella-MarisChinma Egboh, PantongMark Davwar. The burden of occult hepatitis B virus infection in hepatocellular carcinoma in NigeriaGastroenterology, Hepatology and Endoscopy Practice 2023; 3(2): 35 doi: 10.4103/ghep.ghep_34_22
12
Rosa María Ruiz-Calero Cendrero, Bárbara Cancho Castellano, María Victoria Martín Hidalgo-Barquero, María Cruz Cid Parra, Josefa Galán González, María Antonia Fernández Solís, Olga Sánchez García. When can it be useful to look for occult HBV in haemodialysis patients?Nefrología (English Edition) 2020; 40(2): 115 doi: 10.1016/j.nefroe.2020.03.008
13
Amanda Abramson, Alan Menter, Robert Perrillo. Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for managementJournal of the American Academy of Dermatology 2012; 67(6): 1349 doi: 10.1016/j.jaad.2012.04.036
14
Pilar López-Serrano, Elsa de la Fuente Briongos, Elisa Carrera Alonso, Jose Lázaro Pérez-Calle, Conrado Fernández Rodríguez. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapyWorld Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
15
Haiyang Hu, Yangfan Shen, Ming Hu, Yang Zheng, Kaijin Xu, Lanjuan Li. Incidence and Influencing Factors of New Hepatitis B Infections and Spontaneous Clearance: A Large-Scale, Community-Based Study in ChinaFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.717667
16
Purva Sharma, Rani Sawtell, Qiyu Wang, Meghan E. Sise. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney DiseaseAdvances in Kidney Disease and Health 2023; 30(4): 343 doi: 10.1053/j.akdh.2023.04.003
17
Xi Cao, Qing-Hua Shang, Xiao-Ling Chi, Wei Zhang, Huan-Ming Xiao, Mi-Mi Sun, Gang Chen, Yong An, Chun-Lei Lv, Lin Wang, Yue-Min Nan, Cui-Ying Chen, Zong-Nan Tan, Xue-En Liu, Hui Zhuang. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virusWorld Journal of Gastroenterology 2020; 26(10): 1067-1079 doi: 10.3748/wjg.v26.i10.1067
18
Jasmine Samal, Manish Kandpal, Perumal Vivekanandan. Molecular Mechanisms Underlying Occult Hepatitis B Virus InfectionClinical Microbiology Reviews 2012; 25(1): 142 doi: 10.1128/CMR.00018-11
19
Eunsin Bae, Chang-Hun Park, Chang-Seok Ki, Sung-Joo Kim, Wooseong Huh, Ha-Young Oh, Eun-Suk Kang. Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in KoreaScandinavian Journal of Infectious Diseases 2012; 44(10): 788 doi: 10.3109/00365548.2012.680488
20
A Mohammed Abdalhafeez, A Enan Khalid, M Khair Osama, O Hussien Mohammed, Rahim M El Hussein Abdel, M Elkhidir Isam. Prevalence of occult hepatitis B virus (HBV) infections in haemodialysis patients in Khartoum State, Sudan from 2012 to 2014Journal of Medical Laboratory and Diagnosis 2015; 6(4): 22 doi: 10.5897/JMLD2015.0099
21
Carlos Mario Jaramillo, Fernando de La Hoz, Alexandra Porras, Diana di Filippo, Luz Angela Choconta-Piraquive, Edra Payares, Neyla Montes, Maria-Cristina Navas, Pierre Roques. Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, ColombiaPLOS ONE 2017; 12(10): e0181643 doi: 10.1371/journal.pone.0181643
22
Osamu Nagakawa, Yoshiho Miyatomi, Yasuhiro Shigeta, Emi Inayama, Kouichi Murakami, Takehiko Sakai, Takashi Kouno, Motoyuki Masai, Kohji Shirai, Toyohiko Yoshida. Occult Hepatitis B Virus Infection in Japanese Chronic Hemodialysis PatientsTherapeutic Apheresis and Dialysis 2013; 17(3): 289 doi: 10.1111/1744-9987.12006
23
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and ManagementHepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/259148
24
Ying Qu, Chun-Fang Gao, Kun Zhou, Yun-Peng Zhao, Ming-Yi Xu, Lun-Gen Lu. Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis BAnnals of Hepatology 2012; 11(2): 202 doi: 10.1016/S1665-2681(19)31025-7
25
X. Huang, F. B. Hollinger. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic reviewJournal of Viral Hepatitis 2014; 21(3): 153 doi: 10.1111/jvh.12222
26
Yu-Che Chuang, Ying-Ren Chen, Te-Hui Kuo. Cryoglobulinemic glomerulonephritis with underlying occult HBV infection and Waldenström macroglobulinemiaMedicine 2021; 100(7): e24792 doi: 10.1097/MD.0000000000024792
27
Amadin A. Olotu, Adesola O. Oyelese, Lateef Salawu, Rosemary A. Audu, Azuka P. Okwuraiwe, Aaron O. Aboderin. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantationVirology Journal 2016; 13(1) doi: 10.1186/s12985-016-0533-3
28
Mohammad Hossein Ahmadi, Zohreh Sharifi, Ali Ghasemi, Sadegh Abbasian. Occult hepatitis B in Iranian blood donors, an overview of the challenges: A narrative reviewHealth Science Reports 2023; 6(8) doi: 10.1002/hsr2.1466
29
Desalegn Admassu Ayana, A. Mulu, A. Mihret, B. Seyoum, A. Aseffa, R. Howe. Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern EthiopiaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-79392-x
30
Anshu Srivastava, Amrita Mathias, Surender K. Yachha, Rakesh Aggarwal. Occult hepatitis B infection in children with chronic liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(4): 375 doi: 10.1097/MEG.0000000000000294
31
B. Guruprasad, S. Kavitha, B.S. Aruna Kumari, B.R. Vijaykumar, B.G. Sumati, Sinha Mahua, L. Appaji, R.S. Jayshree. Risk of hepatitis B infection in pediatric acute lymphoblastic leukemia in a tertiary care center from South IndiaPediatric Blood & Cancer 2014; 61(9): 1616 doi: 10.1002/pbc.25065
32
Ashish Goel, C. E. Eapen, Debashish Danda. Infliximab and occult Hepatitis B infection: to treat or not to treat?International Journal of Rheumatic Diseases 2013; 16(4): 377 doi: 10.1111/1756-185X.12184
33
Evangelos Cholongitas, Konstantinos Tziomalos, Chrysoula Pipili. Management of patients with hepatitis B in special populationsWorld Journal of Gastroenterology 2015; 21(6): 1738-1748 doi: 10.3748/wjg.v21.i6.1738
34
Sahin Coban, Murat Kekilli, Seyfettin Köklü. Approach and Management of Patients with Chronic Hepatitis B and C During the Course of Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2014; 20(11): 2142 doi: 10.1097/MIB.0000000000000126